After adjustment for age, this difference was borderline significant (OR 1.6; 95% CI 1.0–2.6).
← all excerpts
Diabetes alone should not be a reason for withholding adjuvant chemotherapy for stage III colon cancer.
1
—
—
After adjustment for age, this difference was borderline significant (OR 1.6; 95% CI 1.0–2.6).